Primidone Tablets USP, 250mg recall — Lannett Company Inc. (Class III)
Lannett Company Inc. is recorded by the U.S. Food and Drug Administration (FDA) as recalling Primidone Tablets USP, 250mg — a Class III recall, initiated 2026-04-24 and posted to the FDA enforcement report on 2026-05-27, under recall number D-0533-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.”. From the product description, the form is tablets, the strength given is 250mg, the package is described as 100-count bottle and it is marked Rx only. 1 National Drug Code number is printed in the record: 0527-1231-01. Distribution is recorded as “USA Nationwide” — Nationwide (US), with the recalling firm on record in IN, United States. It is the only recall number the FDA has filed under event ID 98791. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0533-2026 |
|---|---|
| FDA event ID | 98791 |
| Classification | Class III (least serious regulatory tier) |
| Status | Ongoing |
| Recalling firm | Lannett Company Inc. |
| Recall initiated | 2026-04-24 |
| Reported by FDA | 2026-05-27 |
| Report lag | 33 days from initiation to report |
| Distribution | USA Nationwide — Nationwide (US) |
| Firm location on record | IN, United States |
| Product description (source) | Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1231-01. |
Reason reported by FDA
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
13 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
6 identifying values matched by exact pattern in the 18-word product description above; each is a literal substring of it.
| Product named | Primidone Tablets USP |
|---|---|
| Form | Tablets |
| Strength | 250mg |
| Package | 100-count bottle |
| NDC | 0527-1231-01 |
| Marketing category | Rx only |
| Distributed by | Lannett Company, Inc. |
Other indexed recalls from Lannett Company Inc.
3 indexed records name Lannett Company Inc. as the recalling firm, across 3 FDA events, reported 2026-05-27 to 2026-07-08. A coverage-limited activity count over the ingested window, not a quality rating.
| Recall record | Recall number | FDA tier | Strength / form | Reported |
|---|---|---|---|---|
| Dextroamphetamine Saccharate, 5 mg | D-0660-2026 | Class II | 5 mg · Extended-Release Capsules | 2026-07-08 |
| Niacin Extended-release Tablets, 1,000 mg | D-0584-2026 | Class II | 1,000 mg · Extended-Release Tablets | 2026-06-10 |
Other indexed recalls of primidone
6 indexed records name primidone as the recalled substance. Matching is on the product-name prefix of the FDA's own text, so other strengths and packages are included.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| Primidone Tablets, 50 mg | D-0585-2026 | Amneal Pharmaceuticals, LLC | 50 mg · Tablets | 2026-06-17 |
| Primidone Tablets, 50 mg | D-0534-2026 | Golden State Medical Supply Inc. | 50 mg · Tablets | 2026-05-27 |
| Primidone Tablets, 250 mg | D-0535-2026 | Golden State Medical Supply Inc. | 250 mg · Tablets | 2026-05-27 |
| Primidone Tablets, 250 mg | D-0536-2026 | Amerisource Health Services LLC | 250 mg · Tablets | 2026-05-27 |
| Primidone Tablets, 50 mg | D-0537-2026 | Amerisource Health Services LLC | 50 mg · Tablets | 2026-05-27 |
Reported in the same month (2026-05)
48 enforcement reports carry a report date in 2026-05; these 4 are the Class III ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| Busulfan Injection, 60 mg | D-0539-2026 | Sagent Pharmaceuticals | Class III | 2026-05-27 |
| busPIRone Hydrochloride Tablets, 5 mg | D-0511-2026 | Unichem Pharmaceuticals Usa Inc. | Class III | 2026-05-13 |
| Levocarnitine Injection, 1 g/5 mL | D-0494-2026 | American Regent, Inc. | Class III | 2026-05-06 |
| Lidocaine Wound Gel, 0.13% | D-0509-2026 | Water-jel Technologies, LLC | Class III | 2026-05-06 |
Nearest Class III recalls by date
25 of 250 indexed records share the Class III tier; the 5 nearest to 2026-05-27 by report date are listed here.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| Nicotine Transdermal System Patch, 14 mg | D-0550-2026 | Aveva Drug Delivery Systems, Inc. | 14 mg · Transdermal System | 2026-06-03 |
| PRED MILD, 0.12% | D-0551-2026 | Abbvie Inc. | 0.12% · Ophthalmic Suspension | 2026-06-03 |
| Lidocaine HCl Injection, 2% | D-0552-2026 | Eugia US LLC | 2% · Injection | 2026-06-10 |
| Epinephrine Injection, 1mg/mL | D-0581-2026 | Fresenius Kabi Usa, LLC | 1mg/mL · Injection | 2026-06-17 |
| Premier, 8 mL | D-0490-2026 | Premier Dental Products Co | 8 mL · Solution | 2026-04-29 |
Reading this record
Class III is the FDA's own severity tier for the recall action — 25 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 0527-1231-01 at the FDA source to confirm it is covered.
Namespace context: the Class III index (25 records) and the recall hub (250 records, 118 FDA events); Lannett Company Inc. (6 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0533-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0533-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-05-27
- Ingested
- 2026-08-22
- Record hash
eca3b5c5e09e7737
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.